Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterized by symptoms such as chronic cough, sputum production, and dyspnea (shortness of breath). It often includes periods of exacerbations, which are episodes of worsening symptoms.

COPD primarily affects older adults and is strongly associated with smoking, although other factors such as air pollution and genetic predispositions also contribute to its development. The disease requires long-term management and significantly impacts quality of life.

Research has progressed from viewing COPD solely as a respiratory condition to understanding its complex mechanisms involving inflammation, oxidative stress, and genetic factors. This evolving understanding has been crucial in developing current therapeutic approaches that aim to manage symptoms, improve lung function, and enhance the overall well-being of patients.

iNGENū's team of experienced researchers and clinicians specializes in designing and conducting innovative studies. By leveraging enhanced trial design and comprehensive patient-centric strategies, we are committed to accelerating the development of new treatments for COPD.